首页> 外文期刊>BMC Molecular Biology >Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest
【24h】

Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest

机译:丁酸钠通过消除顺铂强加的细胞周期阻滞,增强顺铂的细胞毒性作用

获取原文
           

摘要

Histone deacetylase inhibitors have been proposed as potential enhancers of the cytotoxic effect of cisplatin and other anticancer drugs. Their application would permit the use of lower therapeutic doses and reduction of the adverse side effects of the drugs. However, the molecular mechanisms by which they sensitize the cells towards anticancer drugs are not known in details, which is an obstacle in developing effective therapeutic protocols. In the present work, we studied the molecular mechanisms by which sodium butyrate sensitizes cancer cells towards cisplatin. HeLa cells were treated with 5 mM butyrate, with 8 μM cis-diaminedichloroplatinum II (cisplatin), or with both. Cells treated with both agents showed approximately two-fold increase of the mortality rate in comparison with cells treated with cisplatin only. Accordingly, the life span of albino mice transfected with Ehrlich ascites tumor was prolonged almost two-fold by treatment with cisplatin and butyrate in comparison with cisplatin alone. This showed that the observed synergism of cisplatin and butyrate was not limited to specific cell lines or in vitro protocols, but was also expressed in vivo during the process of tumor development. DNA labeling and fluorescence activated cell sorting experiments showed that cisplatin treatment inhibited DNA synthesis and arrested HeLa cells at the G1/S transition and early S phase of the cell cycle. Western blotting and chromatin immunoprecipitation revealed that this effect was accompanied with a decrease of histone H4 acetylation levels. Butyrate treatment initially reversed the effect of cisplatin by increasing the levels of histone H4 acetylation in euchromatin regions responsible for the G1/S phase transition and initiation of DNA synthesis. This abrogated the cisplatin imposed cell cycle arrest and the cells traversed S phase with damaged DNA. However, this effect was transient and continued only a few hours. The long-term effect of butyrate was a massive histone acetylation in both eu- and heterochromatin, inhibition of DNA replication and apoptosis. The study presents evidence that cell sensitization towards cisplatin by sodium butyrate is due to hyperacetylation of histone H4 in specific chromatin regions, which temporarily abrogates the cisplatin imposed cell cycle arrest.
机译:已提出组蛋白脱乙酰基酶抑制剂作为顺铂和其他抗癌药的细胞毒性作用的潜在增强剂。它们的应用将允许使用较低的治疗剂量并减少药物的不良副作用。但是,尚不清楚它们使细胞对抗癌药物敏感的分子机制,这是开发有效治疗方案的障碍。在目前的工作中,我们研究了丁酸钠使癌细胞对顺铂敏感的分子机制。将HeLa细胞用5 mM丁酸酯,8μM顺式二胺二氯铂II(顺铂)或两者同时处理。与仅用顺铂处理的细胞相比,用两种试剂处理的细胞显示出约两倍的死亡率增加。因此,与单独的顺铂相比,通过顺铂和丁酸的处理,转染了埃里希氏腹水肿瘤的白化病小鼠的寿命延长了几乎两倍。这表明所观察到的顺铂和丁酸酯的协同作用不仅限于特定的细胞系或体外方案,而且还在肿瘤发展过程中在体内表达。 DNA标记和荧​​光激活的细胞分选实验表明,顺铂处理抑制了DNA的合成,并在细胞周期的G1 / S过渡期和早期S期使HeLa细胞停滞。 Western印迹和染色质免疫沉淀表明,这种作用伴随着组蛋白H4乙酰化水平的降低。丁酸盐处理最初通过增加负责G1 / S相变和DNA合成起始的常染色质区域中组蛋白H4乙酰化的水平来逆转顺铂的作用。这废除了顺铂施加的细胞周期停滞,细胞横穿了S期,DNA受损。但是,这种影响是短暂的,仅持续了几个小时。丁酸盐的长期作用是在正常染色质和异染色质中均发生大规模的组蛋白乙酰化,抑制DNA复制和凋亡。该研究提供了证据,表明丁酸钠对细胞对顺铂的敏感性是由于特定染色质区域中组蛋白H4的过度乙酰化所致,从而暂时消除了顺铂施加的细胞周期停滞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号